ArticlemedRxiv : the preprint server for health sciences2026
The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancer.
Anmbreen Jamroze et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.